Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zynerba Pharmaceuticals I...

    NASDAQ: ZYNE · Real-Time Price · USD
    1.30
    0.03 (2.36%)
    At close: Oct 10, 2023, 10:00 PM

    Zynerba Pharmaceuticals Statistics

    Share Statistics

    Zynerba Pharmaceuticals has 53.94M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 53.94M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 35.45M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,201

    FTD / Avg. Volume

    n/a
    		 0.4%

    Short Selling Information

    The latest short interest is 419.98K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 419.98K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.65 and the forward PE ratio is null. Zynerba Pharmaceuticals's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -0.65

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.49

    P/FCF Ratio

    n/a
    		 -0.98

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Zynerba Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.97, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 5.97

    Quick Ratio

    n/a
    		 5.97

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 163.4

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,392,802.88

    Employee Count

    n/a
    		 25

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -215.73K

    Effective Tax Rate

    n/a
    		 0.62%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 1.19, so Zynerba Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.19

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 1.19

    200-Day Moving Average

    n/a
    		 0.62

    Relative Strength Index (RSI)

    n/a
    		 58.62

    Average Volume (20 Days)

    n/a
    		 1,043,239

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -35.25M

    Net Income

    n/a
    		 -34.82M

    EBITDA

    n/a
    		 -34.62M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -0.82
    Full Income Statement

    Balance Sheet

    The company has 50.64M in cash and 334.43K in debt, giving a net cash position of 50.31M.

    Cash & Cash Equivalents

    n/a
    		 50.64M

    Total Debt

    n/a
    		 334.43K

    Net Cash

    n/a
    		 50.31M

    Retained Earnings

    n/a
    		 -274.52M

    Total Assets

    n/a
    		 40.48M

    Working Capital

    n/a
    		 27.84M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -23.03M and capital expenditures -154.1K, giving a free cash flow of -23.18M.

    Operating Cash Flow

    n/a
    		 -23.03M

    Capital Expenditures

    n/a
    		 -154.1K

    Free Cash Flow

    n/a
    		 -23.18M

    FCF Per Share

    n/a
    		 -0.54
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ZYNE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ZYNE.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -8.89

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist